Dopamine-dependent neurotoxicity of α-synuclein:: A mechanism for selective neurodegeneration in Parkinson disease

被引:626
作者
Xu, J
Kao, SY
Lee, FJS
Song, WH
Jin, LW
Yankner, BA [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[2] Childrens Hosp, Div Neurosci, Boston, MA 02115 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
关键词
D O I
10.1038/nm0602-600
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism by which dopaminergic neurons are selectively lost in Parkinson disease (PD) is unknown. Here we show that accumulation of alpha-synuclein in cultured human dopaminergic neurons results in apoptosis that requires endogenous dopamine production and is mediated by reactive oxygen species. In contrast, alpha-synuclein is not toxic in non-dopaminergic human cortical neurons, but rather exhibits neuroprotective activity. Dopamine-dependent neurotoxicity is mediated by 54-83-kD soluble protein complexes that contain alpha-synuclein and 14-3-3 protein, which are elevated selectively in the substantia nigra in PD. Thus, accumulation of soluble alpha-synuclein protein complexes can render endogenous dopamine toxic, suggesting a potential mechanism for the selectivity of neuronal loss in PD.
引用
收藏
页码:600 / 606
页数:7
相关论文
共 30 条
  • [1] Baba M, 1998, AM J PATHOL, V152, P879
  • [2] BREAKEFIELD XO, P NATL ACAD SCI US, V71, P2530
  • [3] APOPTOSIS AND INCREASED GENERATION OF REACTIVE OXYGEN SPECIES IN DOWNS-SYNDROME NEURONS IN-VITRO
    BUSCIGLIO, J
    YANKNER, BA
    [J]. NATURE, 1995, 378 (6559) : 776 - 779
  • [4] The solubility of α-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease
    Campbell, BCV
    McLean, CA
    Culvenor, JG
    Gai, WP
    Blumbergs, PC
    Jäkälä, P
    Beyreuther, K
    Masters, CL
    Li, QX
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) : 87 - 96
  • [5] Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
    Conway, KA
    Lee, SJ
    Rochet, JC
    Ding, TT
    Williamson, RE
    Lansbury, PT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) : 571 - 576
  • [6] Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
    Conway, KA
    Rochet, JC
    Bieganski, RM
    Lansbury, PT
    [J]. SCIENCE, 2001, 294 (5545) : 1346 - 1349
  • [7] Wild-type but not Parkinson's disease-related Ala-53 → Thr mutant α-synuclein protects neuronal cells from apoptotic stimuli
    da Costa, CA
    Ancolio, K
    Checler, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) : 24065 - 24069
  • [8] Drukarch B, 1996, J NEUROSCI, V16, P6038
  • [9] A Drosophila model of Parkinson's disease
    Feany, MB
    Bender, WW
    [J]. NATURE, 2000, 404 (6776) : 394 - 398
  • [10] Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
    Giasson, BI
    Duda, JE
    Murray, IVJ
    Chen, QP
    Souza, JM
    Hurtig, HI
    Ischiropoulos, H
    Trojanowski, JQ
    Lee, VMY
    [J]. SCIENCE, 2000, 290 (5493) : 985 - 989